0 likes | 16 Views
The gastric cancer market size was valued at $2.1 billion in 2021, and is estimated to reach $10.7 billion by 2031, growing at a CAGR of 17.9% from 2022 to 2031.
E N D
Gastric Cancer Market
Gastric Cancer Market Expected to Reach $10.7 Billion by 2031—Allied Market Research Investments in the field of oncology have increased dramatically. Clinical activity levels were at an all-time high in recent years, Furthermore, the ever-increasing proportion of the geriatric population benefits the market, as the disease's diagnosis and prognosis are present in the senior adults. These factors have led to an increase in the demand for gastric cancer treatment, contributing to the gastric cancer growth in the upcoming years. Gastric Cancer Market by Disease Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others), by Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery), by Drug Class Outlook (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), by Route of Administration (Oral, Injectable), by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
List of key players profiled in the report: •F. Hoffmann La Roche Ltd. •Samsung Bioepis •Merck & Co., Inc. •Eli Lilly And Company •Bristol Myers Squibb Company •Novartis AG •Mylan N.V. •Pfizer, Inc. •Celltrion Healthcare Co., Ltd. •Teva Pharmaceutical Industries Ltd. Read More- https://www.alliedmarketresearch.com/press- release/gastric-cancer-market.html
Covid19 Scenario: •The COVID-19 pandemic had a major impact on the global healthcare industry, including the gastric cancer market. The pandemic disrupted the global supply chain, causing raw material shortages and delays in finished product delivery. The pandemic also delayed or cancelled elective surgeries and other medical procedures, affecting the diagnosis and treatment of gastric cancer patients. Covid19 : Request Sample Copy of Report at: https://www.alliedmarketresearch.com/request- sample/74933
ABOUT US Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa 5933 NE Win Sivers Drive#205, Portland, OR 97220 United States, USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141, UK: +44-845-528-1300, Hong Kong: +852-301-84916, India (Pune) help@alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research